Jeff Davies
Vermögen: 468 237 $ am 31.05.2026
Vermögen: 468 237 $ am 31.05.2026
Jeff Davies is currently an Independent Non-Executive Director at Starpharma Holdings Ltd. and a Partner & Founding Director at Centre For Biopharmaceutical Excellence.
Previously, he held positions as Senior Vice President-Sales & Marketing at Thomson Industries, Inc., Executive Vice President & General Manager at CSL Ltd., and Global Head-Plasma Product Research & Development at CSL Behring AG.
Dr. Davies obtained a doctorate degree from Monash University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 929 687 ( 0,22 % ) | 468 237 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.04.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | - |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Develops biological products | Corporate Officer/Principal | - |
Thomson Industries, Inc.
Thomson Industries, Inc. Metal FabricationProducer Manufacturing Manufactures linear motion control products | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Starpharma Holdings Ltd.
Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Thomson Industries, Inc.
Thomson Industries, Inc. Metal FabricationProducer Manufacturing Manufactures linear motion control products | Producer Manufacturing |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Develops biological products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen